Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Israel To Vaccinate Kids With Polio After Tests Show Carriers in South

Israel said on Sunday it was launching a campaign to administer the active polio vaccine to children in its southern region after tests detected at least 1,000 carriers of the virus in that area, though none were found to be ill with the disease.

The Health Ministry said it was recommending that children born after January 2004, but not younger than two months, report to publicly-funded clinics to be administered oral drops of a weakened active virus vaccine beginning on Monday.

Polio, a viral illness that can cause paralysis, is considered highly contagious but has been eradicated in most countries since vaccines were developed in the 1950s.

Most children around the world are now vaccinated at an early age with the inactivated poliovirus vaccine (IPV) as part of routine public health policy. The active oral vaccine (OPV) is administered in places endemic for polio or where the risk of transmission is high.

Israel conducted tests after the virus was detected in sewage samples some weeks ago, and subsequent tests by laboratories abroad provided “indications there are between 1,000 to 2,000 carriers of the virus,” Health Minister Yael German said in an interview with Channel 2 television.

While there have been no reported cases of the disease, a decision was made to take protective steps. Israeli media said the target population numbered about 150,000 children.

“The level of immunisation in Israel is 98 percent and there are no cases of the disease,” German said. “But the virus exists, for now in the south.”

Tests were still being conducted to see whether the immunisation campaign ought to be widened to cover other parts of the country, German added.

A similar immunisation campaign followed a limited outbreak of polio in Israel and Palestinian territories in the late 1980s, at a time when it was believed the disease had been eradicated in the region.

Health groups have said they believe they could rid the world of polio by 2018 with a $5.5 billion vaccination and monitoring plan.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning journalism this Passover.

In this age of misinformation, our work is needed like never before. We report on the news that matters most to American Jews, driven by truth, not ideology.

At a time when newsrooms are closing or cutting back, the Forward has removed its paywall. That means for the first time in our 126-year history, Forward journalism is free to everyone, everywhere. With an ongoing war, rising antisemitism, and a flood of disinformation that may affect the upcoming election, we believe that free and open access to Jewish journalism is imperative.

Readers like you make it all possible. Right now, we’re in the middle of our Passover Pledge Drive and we still need 300 people to step up and make a gift to sustain our trustworthy, independent journalism.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Only 300 more gifts needed by April 30

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.